OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
49
Results
Show all
Save search
Copy query
Show results for
Unknown
(49)
Publication Date
Release Date
2023
(11)
2021
(10)
2022
(8)
2025
(4)
2010
(4)
2018
(3)
2024
(2)
2020
(2)
2016
(1)
2014
(1)
2012
(1)
2011
(1)
2008
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Home OCT Imaging for Newly Diagnosed Neovascular Age-Related Macular Degeneration: A Feasibility Study.
Not available
S-EPMC10997472
|
biostudies-literature
Cite
Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355
|
biostudies-literature
Cite
Large-scale and long-term wildlife research and monitoring using camera traps: a continental synthesis.
Not available
S-EPMC11885691
|
biostudies-literature
Cite
Effect of Aspirin on Disability-free Survival in the Healthy Elderly.
Not available
S-EPMC6426126
|
biostudies-literature
Cite
Effect of Aspirin on All-Cause Mortality in the Healthy Elderly.
Not available
S-EPMC6433466
|
biostudies-literature
Cite
Effect of Aspirin on Cardiovascular Events and Bleeding in the Healthy Elderly.
Not available
S-EPMC6289056
|
biostudies-literature
Cite
A multi-country analysis of COVID-19 hospitalizations by vaccination status.
Not available
S-EPMC10935543
|
biostudies-literature
Cite
SARS-CoV-2 Omicron-B.1.1.529 leads to widespread escape from neutralizing antibody responses.
Not available
S-EPMC8723827
|
biostudies-literature
Cite
Mortality after surgery in Europe: a 7 day cohort study.
Not available
S-EPMC3493988
|
biostudies-literature
Cite
ISARIC-COVID-19 dataset: A Prospective, Standardized, Global Dataset of Patients Hospitalized with COVID-19.
Not available
S-EPMC9339000
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets